RocketDNA Statistics

Total Valuation

RocketDNA has a market cap or net worth of AUD 10.07 million. The enterprise value is 7.64 million.

Market Cap	10.07M
Enterprise Value	7.64M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

RocketDNA has 915.52 million shares outstanding. The number of shares has increased by 31.00% in one year.

Current Share Class	915.52M
Shares Outstanding	915.52M
Shares Change (YoY)	+31.00%
Shares Change (QoQ)	+8.01%
Owned by Insiders (%)	18.59%
Owned by Institutions (%)	26.58%
Float	608.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.39
PB Ratio	1.72
P/TBV Ratio	2.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.97
EV / Sales	1.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.24

Financial Position

The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.23.

Current Ratio	3.16
Quick Ratio	2.86
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	-0.92
Interest Coverage	-5.31

Financial Efficiency

Return on equity (ROE) is -36.75% and return on invested capital (ROIC) is -14.94%.

Return on Equity (ROE)	-36.75%
Return on Assets (ROA)	-12.80%
Return on Invested Capital (ROIC)	-14.94%
Return on Capital Employed (ROCE)	-23.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.96
Inventory Turnover	24.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.50% in the last 52 weeks. The beta is 0.26, so RocketDNA's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+37.50%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	58.35
Average Volume (20 Days)	1,654,423

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RocketDNA had revenue of AUD 7.24 million and -1.92 million in losses. Loss per share was -0.00.

Revenue	7.24M
Gross Profit	3.64M
Operating Income	-1.55M
Pretax Income	-1.79M
Net Income	-1.92M
EBITDA	-825,524
EBIT	-1.55M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 3.45 million in cash and 1.34 million in debt, giving a net cash position of 2.11 million or 0.00 per share.

Cash & Cash Equivalents	3.45M
Total Debt	1.34M
Net Cash	2.11M
Net Cash Per Share	0.00
Equity (Book Value)	5.85M
Book Value Per Share	0.01
Working Capital	3.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -506,326 and capital expenditures -952,106, giving a free cash flow of -1.46 million.

Operating Cash Flow	-506,326
Capital Expenditures	-952,106
Free Cash Flow	-1.46M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 50.22%, with operating and profit margins of -21.45% and -26.57%.

Gross Margin	50.22%
Operating Margin	-21.45%
Pretax Margin	-24.66%
Profit Margin	-26.57%
EBITDA Margin	-11.40%
EBIT Margin	-21.45%
FCF Margin	n/a

Dividends & Yields

RocketDNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.00%
Shareholder Yield	n/a
Earnings Yield	-19.10%
FCF Yield	-14.48%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RocketDNA has an Altman Z-Score of 0.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	n/a